drug-injecting microneedles
Scope
Date
~
-
Korean stock market
S.Korea prepares to launch $7.6 bn stock market stabilization fund
South Korea last week completed the process needed to launch a stock market stabilization fund of 10.76 trillion won ($7.6 billion). The timing for ...
Nov 02, 2022 (Gmt+09:00)
-
Bio & Pharma
No more ineffective drugs due to resistance
L-Base is a pharmaceutical startup specializing in developing drugs for those who become resistant to existing cancer treatments. This year, the Minis...
Nov 01, 2022 (Gmt+09:00)
-
Bio & Pharma
Moderna to stay ahead in mRNA technology: CSO Melissa Moore
CAMBRIDGE, MA – The COVID-19 coronavirus disease has been a curse for many people and companies around the world over the past couple of years...
Oct 14, 2022 (Gmt+09:00)
-
Bio & Pharma
SillaJen shares jump as exchange maintains listing, allows resumed trade
Shares in South Korea’s scandal-hit biotechnological company SillaJen Inc. soared on Thursday after the local exchange decided to maintain the...
Oct 13, 2022 (Gmt+09:00)
-
Korean stock market
Korea to complete process for stock market fund in mid-Oct
South Korea is set to complete the process for a stock market stabilization fund of 10 trillion won ($7 billion) by the middle of this month, to be ...
Oct 04, 2022 (Gmt+09:00)
-
Bio & Pharma
Sanofi, Korean biotech Lemonex ink material transfer agreement
South Korean biotech Lemonex Inc. has signed a material transfer agreement (MTA) with global pharmaceutical giant Sanofi S.A. to use the Korean bi...
Sep 14, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum
South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...
Sep 13, 2022 (Gmt+09:00)
-
Energy
Hanwha Solutions, GS Energy to produce sheets for solar power
South Korea’s Hanwha Solutions Corp., Hanwha Group’s energy services arm, is entering into a sizeable co-investment to strengthen its so...
Sep 07, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean bio firms look to pills, patches for people who fear needles
Getting shots of a drug or vaccine over a long period is not easy for many people.That's probably why global biopharmaceutical companies and biotech...
Aug 24, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare logs record-high Q2 revenue on back of Remsima
Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.’s global marketing affiliate, posted its record-high second-quar...
Aug 17, 2022 (Gmt+09:00)
-
Real estate
Hanwha Life to spur global real estate investment via US subsidiary
South Korea’s Hanwha Life Insurance Co. is set to kick off direct investment in overseas real estate via its subsidiary in the US, according t...
Aug 10, 2022 (Gmt+09:00)
-
Bio & Pharma
TiumBio inks licensing deal with China's Hansoh for endometriosis drug
South Korean biotech TiumBio Co. has signed a technology transfer agreement of its endometriosis and uterine myoma treatment candidate with China&rs...
Aug 10, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Daewoo Shipbuilding may split up to find new owners
South Korea is considering splitting Daewoo Shipbuilding & Marine Engineering Co. into two units to facilitate the sale of the debt-ridden shipb...
Jul 25, 2022 (Gmt+09:00)
-
Food & Beverage
Shinsegae to launch wholly owned US subsidiary on alternative meat
Shinsegae Food Inc. announced Thursday it will launch its US subsidiary focused on alternative meat. The food arm of Shinsegae Inc. will inject...
Jul 22, 2022 (Gmt+09:00)
-
Aerospace & Defense
South Korea’s Mirae Asset Group bets $100 million on SpaceX
Mirae Asset Securities Co. is poised to invest $100 million in US spacecraft and satellite communication corporation SpaceX. The South Korean f...
Jul 15, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals signs epilepsy drug deal with Brazil’s Eurofarma
South Korea’s SK Biopharmaceuticals Co. has signed a deal to license out its technology for Cenobamate, an antiepileptic drug, to Brazil&rsquo...
Jul 15, 2022 (Gmt+09:00)
-
Korean startups
Dunamu to nurture 500 Korean startups to create jobs
Dunamu, the operator of South Kora’s largest cryptocurrency exchange Upbit, has launched two programs to support 500 startups over the next fi...
Jul 12, 2022 (Gmt+09:00)
-
Korean startups
KT injects $23 mn into fabless startup Rebellions
South Korean fabless startup Rebellions Inc. received a 30 billion won ($23 million) extension to its Series A funding from telecom giant KT Corp.KT...
Jul 06, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech firms fold COVID-19 therapeutics development businesses
A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...
Jul 04, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech L&C Bio issues convertible bonds worth $46 mn
South Korean biotech company L&C Bio, which specializes in tissue regeneration treatment, is poised to ramp up its expansion into the Chinese ma...
Jun 30, 2022 (Gmt+09:00)
language -
Bio & Pharma
1 in 4 biotech firms struggles with decreasing cash reserves
South Korea’s biotechnology firms – public and private alike – are facing increasingly negative financial conditions. T...
Jun 26, 2022 (Gmt+09:00)
-
Bio & Pharma
Pharma companies jump into $3 bn pet care market
South Korean pharmaceutical companies are jumping into the animal medicine and diagnostics market to target the rapidly growing pet care market, whi...
Jun 24, 2022 (Gmt+09:00)
-
Energy
SK Ecoplant to inject $100 mn in Korean solar energy firm Topsun
South Korea's top waste management company SK Ecoplant Co., a unit of conglomerate SK Inc., is slated to complete talks to invest 130 billion won ($...
Jun 23, 2022 (Gmt+09:00)
-
ASK 2022
[ASK 2022] Infrastructure benefits from inflation and population growth: Sera Global
Infrastructure is stronger than ever amid the current macroeconomic risks, and investors will see greater opportunities in the ...
Jun 02, 2022 (Gmt+09:00)
-
Electric vehicles
Hyundai, Kia to inject $16.6 bn into EV production in South Korea
The Hyundai Motor Group announced the conglomerate’s domestic investment blueprint on Wednesday. The backbone of the investment plan is to ma...
May 18, 2022 (Gmt+09:00)
language -
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Korean startups
CJ ventures into fandom platform with $17 mn investment
CJ Group, one of South Korea’s largest family run conglomerates, or chaebol, is venturing into the fandom platform business with a 22.4 billio...
May 11, 2022 (Gmt+09:00)
-
Pension funds
Korea Post to hire two GPs for global infrastructure debt
Korea Post, South Korea's state-run postal service agency, said on April 14 that its insurance arm will select two asset managers for a maxi...
Apr 14, 2022 (Gmt+09:00)
-
Bio & Pharma
HK inno.N receives sales permit for ulcer treatment in China
HK inno.N is expediting its global expansion with its latest drug K-Cab designed to treat peptic ulcers.The South Korean pharmaceutical company an...
Apr 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi stands out with own drugs as Korean rivals sell imports
South Korea’s Hanmi Pharmaceutical Co. generated sales of more than 1 trillion won ($812.3 million) from its own medicines last year on strong...
Apr 11, 2022 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand